novartis glp 1 drug GLP-1 pills are on the way. Here's what to know : Short Wave : NPR Weight loss with GLP-1 medicines
Description
ICMR Guidelines for management of type 2 diabetes 2018
Fatty liver disease: Is it nonalcoholic fatty liver disease or obesity-associated fatty liver disease
Eric Topol, MD If this signal holds, GLP-1 drugs may turn out to be reward-pathway regulators disguised as metabolic therapies
After a median follow-up of 3.2 years (duration of drug exposure 2.4 years) the primary outcome was reduced in the exenatide treated group, but this difference just missed achieving statistical significance (HR 0.91
J Steroid Biochem Mol Biol
